anavar steroid

Use Solkotrihovak content increases the humoral  class antibodies to surface antigens of lactobacilli increase total slgA, as well as to increased  antibodies in vaginal secretions. Despite the fact that some time after drug administration content  antibodies decreases to baseline, the protective effect of the drug, which reduces the risk of re-infection persists.

Activation of innate immunity.
In the experiments in vitro and anavar steroid in vivo has been shown that the use of polyclonal Solkotrihovak activates B cells and stimulates the production of non-specific IgA class antibodies. In in vitro experiments in the study of biological materials derived from animals subjected to vaccination Solkotrihovak, a significant short-term increase in phagocytic activity of macrophages was found, as well as – the cytotoxic activity of T-lymphocytes.

Mobilization of specific and nonspecific immunologic reactions to vaccination against  directed against the antigen contained in the specimen  that contributes to elimination of atypical forms lactobacilli  increase the number of rods and, as a result, restoration of the normal microflora and normalization pH of the vaginal mucosa.
Vaccination Solkotrihovak not only stabilizes the vaginal microflora, but also prevents the risk of reinfection and relapse in 80% of patients with recurrent vaginal infections.

appointment

Prevention and treatment:

 

  • recurrent bacterial vaginosis
  • recurrent trichomoniasis in women

Contraindications

 

  • acute infectious diseases
  • active tuberculosis
  • diseases of the hematopoietic system (acute leukemia, and others.)
  • heart disease and kidney failure with decompensation
  • state primary and secondary immunodeficiency
  • Hypersensitivity anavar steroid to the drug

special instructions

 

  • in the case of acute trichomoniasis flow or if symptoms of bacterial vaginosis Solkotrihovak vaccination should only be carried out in combination with Etiotropic treatment;
  • Solkotrihovak should not be administered with sexually transmitted diseases (gonorrhea, syphilis);
  • not recommended for children under 15 years;
  • to date clinical trial data on the use of Solkotrihovak during pregnancy and lactation are not available, so the use of the drug with respect to these categories of patients is possible if the expected benefit to the mother outweighs the potential risk to the fetus;
  • during treatment with immunosuppressants and / or radiation therapy may be a partial or complete loss of efficiency Solkotrihovak;
  • use of the drug does not affect the ability to operate machinery and driving vehicles;
  • should not use the drug in the presence of visible physical damage vial or ampoule lyophilisate with water for injection, with the fuzzy marking, in violation of the physical properties of the dissolved drug.Use  content increases the humoral  class antibodies to surface antigens of lactobacilli increase total , as well as to increased  antibodies in vaginal secretions. Despite the fact that some time after drug administration content antibodies decreases to baseline, the protective effect of the drug, which reduces the risk of re-infection persists.Activation of innate immunity.
    In the experiments in vitro and in vivo has been shown that the use of polyclonal Solkotrihovak activates B cells and stimulates the production of non-specific anavar steroid class antibodies. In in vitro experiments in the study of biological materials derived from animals subjected to vaccination Solkotrihovak, a significant short-term increase in phagocytic activity of macrophages was found, as well as – the cytotoxic activity of T-lymphocytes.Mobilization of specific and nonspecific immunologic reactions to vaccination against Solkotrihovak directed against the antigen contained in the specimen that contributes to elimination of atypical forms lactobacilli Doderlein increase the number of rods and, as a result, restoration of the normal microflora and normalization pH of the vaginal mucosa.
    Vaccination Solkotrihovak not only stabilizes the vaginal microflora, but also prevents the risk of reinfection and relapse in 80% of patients with recurrent vaginal infections.

    appointment

    Prevention and treatment:

     

    • recurrent bacterial vaginosis
    • recurrent trichomoniasis in women

    Contraindications

     

    • acute infectious diseases
    • active tuberculosis
    • diseases of the hematopoietic system (acute leukemia, and others.)
    • heart disease and kidney failure with decompensation
    • state primary and secondary immunodeficiency
    • Hypersensitivity to the drug

    special instructions

     

    • in the case of acute trichomoniasis flow or if symptoms of bacterial vaginosis Solkotrihovak vaccination should only be carried out in combination with Etiotropic treatment;
    • Solkotrihovak should not be administered with sexually transmitted diseases (gonorrhea, syphilis);
    • not recommended for children under 15 years;
    • to date clinical trial data on the use of Solkotrihovak during pregnancy and lactation are not available, so the use of the drug with respect to these categories of patients is possible if the expected benefit to the mother outweighs the potential risk to the fetus;
    • during treatment with immunosuppressants and / or radiation therapy may be a partial or complete loss of efficiency anavar steroid;
    • use of the drug does not affect the ability to operate machinery and driving vehicles;
    • should not use the drug in the presence of visible physical damage vial or ampoule lyophilisate with water for injection, with the fuzzy marking, in violation of the physical properties of the dissolved drug.

steroide anabolisant achat steroide achat achat steroide musculation